Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 3/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | ESRRA | P11474 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10764797 | 1.00 | CXCR4 (0.63) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| Hydrochloric Acid SCHEMBL31169762 | 0.98 | CXCR4 (0.61) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL10349210 | 0.98 | CXCR4 (0.65) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL23023087 | 0.94 | CXCR4 (0.65) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| Decarboxylated Derivative SCHEMBL25372998 | 0.92 | SIGMAR1 (0.57) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL2934330 | 0.90 | CXCR4 (0.69) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL16083006 | 0.90 | CXCR4 (0.69) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL18096446 | 0.87 | CXCR4 (0.57) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL8826390 | 0.85 | HTT (0.58) | CXCR4NPC1RAB9ASIGMAR1HDAC6 | |
| SCHEMBL8493195 | 0.83 | ALDH1A1 (0.56) | CXCR4NPC1RAB9ASIGMAR1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2025-05-01 | — | — | US | disclosed |
| CN-118956250-B | High-strength high-weather-resistance elastic coating and preparation method and application thereof | 天津森聚柯密封涂层材料有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-4469438-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| CN-118956250-A | High-strength high-weather-resistance elastic coating and preparation method and application thereof | 天津森聚柯密封涂层材料有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118834594-A | Single-component elastic coating and preparation method and application thereof | 沧州渤海新区高内聚能化工有限公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | PURDUE RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | US | disclosed |
| WO-2023209336-A1 | ANTI-INFECTIVE AGENTS | UNIVERSITY OF DUNDEE (GB) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023146987-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146987-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| CN-115433508-B | Single-component high-strength elastic coating and preparation method and application thereof | 天津森聚柯密封涂层材料有限公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-0661283-A1 | BRAIN CELL PROTECTIVE | TORAY INDUSTRIES, INC. (JP) | 1995-07-05 | — | — | EP | disclosed |
| US-5391808-A | Lubricant and synthetic polymer additives for heat and oxidation resistance | CIBA-GEIGY CORPORATION (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0585202-A1 | N,N'-alkenylene amine/mercaptotolyl-imidazole blends as high temperature antioxidants for elastomers | CIBA-GEIGY AG (CH) | 1994-03-02 | — | — | EP | disclosed |
| US-5283367-A | Antioxidants for lubricants and polymers | CIBA-GEIGY CORPORATION (US) | 1994-02-01 | — | — | US | disclosed |
| US-5240976-A | For automobile, wire and cable uses | CIBA-GEIGY CORPORATION (US) | 1993-08-31 | — | — | US | disclosed |
| EP-0514333-A2 | Substituted 1,4-diamino-2-butene stabilizers and stabilized compositions | CIBA-GEIGY AG (CH) | 1992-11-19 | — | — | EP | disclosed |
| US-4503249-A | ORGANIC COMPOUNDS | PHILLIPS PETROLEUM COMPANY (US) | 1985-03-05 | — | — | US | disclosed |
| US-4401640-A | IRON II HEXACYANOCOBALTATE | PHILLIPS PETROLEUM COMPANY (US) | 1983-08-30 | — | — | US | disclosed |
| US-4394298-A | RUTHENIUM/III/ HEXACYANOCOBALTATE, SUPPORT | PHILLIPS PETROLEUM COMPANY (US) | 1983-07-19 | — | — | US | disclosed |
| US-4163025-A | Process for the production of benzylamine and dibenzylamine | MILES LABORATORIES, INC. (US) | 1979-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | CNKSR1, UGT1A1, REV1 | CXCR4 424/4885NPC1 1403/4885RAB9A 190/4885 |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | MAOB, BCAT2, AADAT | CXCR4 4067/4885NPC1 3012/4885RAB9A 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.